[go: up one dir, main page]

BR1100756KB1 - prophylactic or therapeutic drug for glomerular nephropathy or nephritis. - Google Patents

prophylactic or therapeutic drug for glomerular nephropathy or nephritis.

Info

Publication number
BR1100756KB1
BR1100756KB1 BRPP1100756-7KB1A BR1100756A BR1100756KB1 BR 1100756K B1 BR1100756K B1 BR 1100756KB1 BR 1100756 A BR1100756 A BR 1100756A BR 1100756K B1 BR1100756K B1 BR 1100756KB1
Authority
BR
Brazil
Prior art keywords
stands
prophylactic
therapeutic drug
nephritis
optionally substituted
Prior art date
Application number
BRPP1100756-7KB1A
Other languages
Portuguese (pt)
Inventor
Kohei Nishikawa
Yumiko Shibouta
Keiji Kubo
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of BR1100756KB1 publication Critical patent/BR1100756KB1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

This invention relates to prophylactic or therapeutic drug for diabetic nephropathy or glomerulonephritis, comprising, as an active ingredient, a compound or salt thereof represented by general formula (I) <CHEM> wherein R<1> stands for H or an optionally substituted hydrocarbon residue; R<2> stands for an optionally esterified carboxyl group; R<3> stands for a group actually or potentially capable of forming an anion; X shows that the phenylene and phenyl groups bind to each other directly or through a spacer having an atomic chain length of two or less; n stands for 1 or 2; ring A stands for a benzene ring having an optional substituent in addition to R<2>; Y stands for a bond, -O-, -S(O)m- (wherein m stands for 0, 1 or 2), or -N(R<4>)- (wherein R<4> stands for H or an optionally substituted alkyl group).
BRPP1100756-7KB1A 1993-04-22 1997-05-12 prophylactic or therapeutic drug for glomerular nephropathy or nephritis. BR1100756KB1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9594293 1993-04-22

Publications (1)

Publication Number Publication Date
BR1100756KB1 true BR1100756KB1 (en) 2011-10-18

Family

ID=14151326

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPP1100756-7KB1A BR1100756KB1 (en) 1993-04-22 1997-05-12 prophylactic or therapeutic drug for glomerular nephropathy or nephritis.

Country Status (12)

Country Link
US (7) US5719173A (en)
EP (1) EP0622077B1 (en)
JP (1) JP3810020B2 (en)
AT (1) ATE194284T1 (en)
BR (1) BR1100756KB1 (en)
CA (1) CA2121871C (en)
CY (1) CY2204B1 (en)
DE (1) DE69425085T2 (en)
DK (1) DK0622077T3 (en)
ES (1) ES2149226T3 (en)
GR (1) GR3033862T3 (en)
PT (1) PT622077E (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3810020B2 (en) 1993-04-22 2006-08-16 武田薬品工業株式会社 Preventive or therapeutic agent for kidney disease
JP2003306432A (en) * 1993-04-22 2003-10-28 Takeda Chem Ind Ltd Prophylactic or therapeutic agent for renal disease
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
EP0760316B1 (en) * 1995-02-10 2004-03-17 Enshu Co., Ltd. Seat belt suspender
JPH10513202A (en) * 1996-06-11 1998-12-15 ゾナジェン，インコーポレイテッド Chitosan drug delivery system
AU5576498A (en) * 1997-02-05 1998-08-26 Sankyo Company Limited Prophylactic or therapeutic agent for diabetic complication
US8273866B2 (en) * 2002-02-20 2012-09-25 Merck Sharp & Dohme Corp. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)
PL356422A1 (en) 2000-02-18 2004-06-28 Takeda Chemical Industries, Ltd. Tnf-alpha inhibitors
US7087608B2 (en) 2000-03-03 2006-08-08 Robert Charles Atkins Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
WO2004071534A1 (en) * 2003-02-17 2004-08-26 Takeda Pharmaceutical Company Limited Preventives/remedies for kidney diseases
US7021099B2 (en) * 2003-06-12 2006-04-04 General Motors Corporation Extraction system for hot formed parts
US7301036B2 (en) * 2003-12-19 2007-11-27 Merck & Co., Inc. Cyclic guanidines, compositions containing such compounds and methods of use
JPWO2006046528A1 (en) * 2004-10-29 2008-05-22 興和株式会社 Treatment for glomerular diseases
TW200719896A (en) * 2005-04-18 2007-06-01 Astrazeneca Ab Combination product
AR057455A1 (en) 2005-07-22 2007-12-05 Merck & Co Inc INHIBITORS OF HIV REVERSE TRANSCRIPTASE AND PHARMACEUTICAL COMPOSITION
TWI415634B (en) * 2007-03-28 2013-11-21 Takeda Pharmaceutical Solid pharmaceutical composition
CN102196809B (en) * 2008-10-22 2013-06-26 协和发酵麒麟株式会社 Agent for treatment of diabetic nephropathy
CN102933233A (en) 2010-06-17 2013-02-13 日东电工株式会社 Agent for treating renal fibrosis

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128256A (en) * 1987-01-12 1992-07-07 Stratagene DNA cloning vectors with in vivo excisable plasmids
DE3928177A1 (en) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K BENZIMIDAZOLE, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
CA2016710A1 (en) * 1989-05-15 1990-11-15 Prasun K. Chakravarty Substituted benzimidazoles as angiotensin ii antagonists
ATE113281T1 (en) * 1989-08-02 1994-11-15 Takeda Chemical Industries Ltd PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND APPLICATION.
DE3927170A1 (en) * 1989-08-17 1991-02-21 Boehringer Ingelheim Kg INHALATOR
US5250554A (en) * 1989-10-24 1993-10-05 Takeda Chemical Industries, Ltd. Benzimidazole derivatives useful as angiotensin II inhibitors
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
EP0430300A3 (en) * 1989-12-01 1992-03-25 Takeda Chemical Industries, Ltd. Xanthine derivatives, their production and use
EP0434038A1 (en) * 1989-12-22 1991-06-26 Takeda Chemical Industries, Ltd. Fused imidazole derivatives, their production and use
EP0442473B1 (en) * 1990-02-15 1998-08-19 Takeda Chemical Industries, Ltd. Pyrimidinedione derivatives, their production and use
US5284661A (en) * 1990-02-22 1994-02-08 Takeda Chemical Industries, Ltd. Fused thiophene derivatives, their production and use
CA2037630C (en) * 1990-03-07 2001-07-03 Akira Morimoto Nitrogen-containing heterocylic compounds, their production and use
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
AU7820091A (en) * 1990-06-08 1991-12-12 Roussel-Uclaf New benzimidazole derivatives, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
DK0533840T3 (en) * 1990-06-22 1996-12-30 Du Pont Treatment of chronic renal failure with imidazole-angiotensin II receptor antagonists
AU8405691A (en) * 1990-09-04 1992-03-30 Yamanouchi Pharmaceutical Co., Ltd. Novel tetrahydrobenzazole derivative
AU636066B2 (en) * 1990-10-30 1993-04-08 Takeda Chemical Industries Ltd. Thienoimidazole derivatives, their production and use
GB9027210D0 (en) * 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
TW274551B (en) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd Biphenyl substituted heterocyclic compounds their production and pharmaceutical compositions comprising them
ATE264323T1 (en) * 1992-09-14 2004-04-15 Takeda Chemical Industries Ltd HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANGIOTENSIN II ANTAGONISTS
EP0603712B1 (en) * 1992-12-22 2001-08-16 Takeda Chemical Industries, Ltd. Heterocyclic compounds having angiotensin II antagonistic activity and use thereof
JP3810020B2 (en) * 1993-04-22 2006-08-16 武田薬品工業株式会社 Preventive or therapeutic agent for kidney disease

Also Published As

Publication number Publication date
US7135490B2 (en) 2006-11-14
PT622077E (en) 2000-10-31
EP0622077A1 (en) 1994-11-02
US6686383B2 (en) 2004-02-03
US20020045652A1 (en) 2002-04-18
US5889036A (en) 1999-03-30
DE69425085T2 (en) 2000-11-09
DE69425085D1 (en) 2000-08-10
JP3810020B2 (en) 2006-08-16
US6319938B1 (en) 2001-11-20
DK0622077T3 (en) 2000-10-23
US6040324A (en) 2000-03-21
CY2204B1 (en) 2002-11-08
US20030114509A1 (en) 2003-06-19
CA2121871A1 (en) 1994-10-23
ATE194284T1 (en) 2000-07-15
CA2121871C (en) 2006-12-12
US20040082636A1 (en) 2004-04-29
EP0622077B1 (en) 2000-07-05
JPH072667A (en) 1995-01-06
US5719173A (en) 1998-02-17
ES2149226T3 (en) 2000-11-01
US6469037B2 (en) 2002-10-22
GR3033862T3 (en) 2000-10-31

Similar Documents

Publication Publication Date Title
BR1100756KB1 (en) prophylactic or therapeutic drug for glomerular nephropathy or nephritis.
DE69725978D1 (en) CHALCON DERIVATIVES AND MEDICINES THAT CONTAIN THEM
NO307047B1 (en) Novel hydroxyethylaminosulfonamides useful as retroviral protease inhibitors, pharmaceutical compositions containing them, and their use
DK0705254T3 (en) Phenyl heterocyclic compounds as cyclooxygenase-2 inhibitors
DK0675886T3 (en) Aminomethylene-substituted non-aromatic heterocycles and their use as substance P antagonists
DE60131967D1 (en) Nr1h4 nuclear receptor binding compounds
DE69820248D1 (en) PYRROLIDIN DERIVATIVES HAVING A PHOSPHOLIPASE A2 INHIBITING EFFECT
SG45336A1 (en) A pharmaceutical composition for angiotens ii-mediated diseases
HU9603433D0 (en) Novel 4-6-diaryl-pyrimidine-derivatives and salts thereof
SE0302760D0 (en) New compounds
ATE433971T1 (en) NEW AZOLE DERIVATIVES
ATE377602T1 (en) MORPHINAN DERIVATIVES AND THEIR MEDICAL APPLICATIONS
DE69709493D1 (en) Substituted indazole derivatives
AU8811401A (en) Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
EP0604354A3 (en) Antidepressant and anti-parkinsonian compounds.
EP1329218A4 (en) AGENTS FOR PREVENTIVE AND TREATING PORTAL HYPERTENSION
EP0604355A3 (en) Heterocyclic compounds substituted by an alkyl group.
DE60202575D1 (en) 3,4-dihydro-1H-naphthalene derivatives as highly selective cyclooxygenase-2 inhibitors
ATE386716T1 (en) BIPHENYL DERIVATIVES
TH41374A (en) New class of pharmaceutical compounds